Sal Trading, LLC Astrazeneca PLC Transaction History

Sal Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$66.81 - $80.83 $3.26 Million - $3.94 Million	48,800 Added 163.2%	78,702 $6.14 Million
Q1 2024 May 07, 2024	BUY	$61.03 - $69.57 $586,010 - $668,011	9,602 Added 47.3%	29,902 $2.03 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $92,835 - $103,920	1,500 Added 7.98%	20,300 $1.37 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $1.22 Million - $1.35 Million	18,800 New	18,800 $1.27 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $4.28 Million - $5.56 Million	-79,000 Reduced 50.54%	77,300 $5.24 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $3.49 Million - $8.95 Million	65,900 Added 72.9%	156,300 $8.57 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $3.24 Million - $3.89 Million	54,700 Added 153.22%	90,400 $5.97 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $8.5 Million - $10.2 Million	-152,576 Reduced 81.04%	35,700 $2.37 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $10.2 Million - $12 Million	188,276 New	188,276 $11 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sal Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Sal Trading, LLC with notifications on news.